Sign in
4

Changes in Ownership

Aligos Therapeutics, Inc. Filed Acc 0001610717-24-000123

Options or other derivatives

  • See Remarks acquired 308,940 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
Derivatives
Calhoun Lesley Ann See Remarks 2024-03-01 Grant or award · Stock Option (Right to Buy) +308,940 308,940 D
Loading xslF345X05/form4.xml…